Nuformix plc (LON:NFX – Get Free Report) shares reached a new 52-week low during trading on Thursday . The company traded as low as GBX 0.15 ($0.00) and last traded at GBX 0.18 ($0.00), with a volume of 1542370 shares trading hands. The stock had previously closed at GBX 0.18 ($0.00).
Nuformix Stock Up 2.3 %
The stock has a 50-day simple moving average of GBX 0.19 and a two-hundred day simple moving average of GBX 0.22. The company has a quick ratio of 3.35, a current ratio of 1.51 and a debt-to-equity ratio of 1.17. The firm has a market cap of £1.47 million, a PE ratio of -1.63 and a beta of 0.28.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Recommended Stories
- Five stocks we like better than Nuformix
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- First Solar Stock: The Dawn of a New Rally in Share Prices
- What Does Downgrade Mean in Investing?
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- Bank Stocks – Best Bank Stocks to Invest In
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
